Here are 15 statistics on how ophthalmologists reacted to changing healthcare costs and regulations in 2012, according to Medscape's Physician Compensation Report 2013.
Participation in payment models:
Accountable care organization – 8 percent
Not in an ACO but within the year – 6 percent
Cash-only – 4 percent
Concierge – 3 percent
Will you stop taking Medicaid or Medicare Patients?
I will continue taking new and current patients – 61 percent
I have not yet decided – 30 percent
I plan to stop taking new patients – 7 percent
I plan to stop taking current patients – 2 percent
Will you drop insurers who pay poorly?
Yes – 42 percent
No, I need all payors – 22 percent
No, that’s inappropriate behavior – 12 percent
Do you discuss cost of treatment with patients?
Occasionally, if the patient brings it up – 42 percent
I regularly discuss with patients – 39 percent
Never, because I don’t know the costs – 5 percent
Never, I don’t feel it’s appropriate – 5 percent
More Articles on Ophthalmology:
Regeneron Acquires Two Ophthalmological Antibody Programs from Sanofi
Dr. Brian Ranelle, Texas Eye & Laser Center Introduce SmartVision for Cataract Surgery
Liquidia Technologies to Develop Ophthalmology-Focused Company
Participation in payment models:
Accountable care organization – 8 percent
Not in an ACO but within the year – 6 percent
Cash-only – 4 percent
Concierge – 3 percent
Will you stop taking Medicaid or Medicare Patients?
I will continue taking new and current patients – 61 percent
I have not yet decided – 30 percent
I plan to stop taking new patients – 7 percent
I plan to stop taking current patients – 2 percent
Will you drop insurers who pay poorly?
Yes – 42 percent
No, I need all payors – 22 percent
No, that’s inappropriate behavior – 12 percent
Do you discuss cost of treatment with patients?
Occasionally, if the patient brings it up – 42 percent
I regularly discuss with patients – 39 percent
Never, because I don’t know the costs – 5 percent
Never, I don’t feel it’s appropriate – 5 percent
More Articles on Ophthalmology:
Regeneron Acquires Two Ophthalmological Antibody Programs from Sanofi
Dr. Brian Ranelle, Texas Eye & Laser Center Introduce SmartVision for Cataract Surgery
Liquidia Technologies to Develop Ophthalmology-Focused Company